EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016–2022)

Timon Stephen Emaely iD, Alex Mremi iD, Elizabeth F Msoka, Rebeca Mutashobya, Blandina T Mmbaga iD, Kondo Chilonga

PLOS One · 06.11.2026 · 21 (11) · e0361615

DOI: 10.1371/journal.pone.0361615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.11.2026. Verfasst von Timon Stephen Emaely und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, KCMC University, Moshi, Tanzania. Hauptthemen laut MEDLINE: Breast Neoplasms, Male. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesinstitut für Sportwissenschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Male breast cancer (BC) is rare, accounting to approximately 1% of all breast cancers worldwide. Patients often present with advanced disease, contributing to poor outcomes. This study aimed to estimate two-year overall survival (OS) and identify clinicopathological and health-system–related predictors of survival among men with breast cancer treated at Kilimanjaro Christian Medical Centre (KCMC).

Methods

A retrospective cohort study was conducted among 55 histologically confirmed male BC patients managed at KCMC between 2016 and 2022. The primary outcome was two-year overall survival, defined as time from histological diagnosis to death from any cause or censoring at two years. The dependent variables were clinical and pathological factors and the key independent variable was overall survival (OS). Descriptive statistics summarized participants characteristics. Kaplan–Meier curves, log-rank and Cox proportional hazards regression were used to estimate the OS and the factors associated. A p-value 70 years (p = 0.009), stage IV disease (p = 0.005), delayed receipt of histopathological results (> 2 weeks), delayed surgery (>6 weeks), and non-receipt of hormonal therapy or radiotherapy.

Conclusion

Male BC in Northern Tanzania remains a disease for older who frequently present with advanced-stages. Two-year overall survival remains suboptimal and is strongly influenced by advanced disease stage, older age, diagnostic and treatment delays, and limited access to adjuvant therapies. Strengthening early diagnosis, timely pathology reporting, and access to radiotherapy and hormonal therapy may substantially improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast Neoplasms, MaleHumansTanzaniaMaleRetrospective StudiesMiddle AgedAgedPrognosisNeoplasm StagingAdultKaplan-Meier Estimate

Autor:innen und Institutionen

  • Department of General Surgery, KCMC University, Moshi, Tanzania.
  • Department of General Surgery, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
  • Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Cancer Care Centre, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

ORCID-Profile: Timon Stephen Emaely, Alex Mremi, Blandina T Mmbaga

Förderung

  • Bundesinstitut für Sportwissenschaft

Zitieren

APA

Emaely, T. S., Mremi, A., Msoka, E. F., Mutashobya, R., Mmbaga, B. T., & Chilonga, K. (2026). Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016–2022). PLOS One, 21(11), e0361615. https://doi.org/10.1371/journal.pone.0361615

Vancouver

Emaely TS, Mremi A, Msoka EF, Mutashobya R, Mmbaga BT, Chilonga K. Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016–2022). PLOS One. 2026;21(11):e0361615. doi:10.1371/journal.pone.0361615

BibTeX
@article{Emaely2026,
  author = {Emaely, Timon Stephen and Mremi, Alex and Msoka, Elizabeth F and Mutashobya, Rebeca and Mmbaga, Blandina T and Chilonga, Kondo},
  title = {Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016–2022)},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0361615},
  doi = {10.1371/journal.pone.0361615}
}
Kostenlos starten →